Hyperaldosteronism (Conn's Syndrome)

100%

When the underlying neoplasm is malignant (rare adrenocortical carcinoma producing aldosterone), DC 7914 verbatim — 100% during/after surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure; mandatory VA examination at six months; any rating change subject to § 3.105(e); if no recurrence or metastasis, rate-as residuals of endocrine dysfunction (hypertension under DC 7101, hypokalemia, cardiac sequelae).

0%

Evaluate as a malignant (DC 7914) or benign (DC 7915) endocrine neoplasm, as appropriate. Most cases — Conn's syndrome from a benign aldosterone-producing adrenal adenoma — are rated under DC 7915, with the disability rated entirely on the basis of the resulting dysfunction (hypertension under § 4.104, DC 7101; hypokalemia and its consequences; muscle weakness; cardiac sequelae). Adrenocortical carcinoma producing aldosterone follows DC 7914 (100% during/after active treatment; mandatory VA exam at 6 months; rating change subject to § 3.105(e)).